+ Follow merck Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 2259525
[Title] => Drugmaker Merck acquires Prometheus for nearly $11 bn
[Summary] => The company is developing a treatment for autoimmune diseases, including ulcerative colitis and Crohn's disease, dubbed PRA023.
[DatePublished] => 2023-04-17 07:51:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] => https://media.philstar.com/photos/2021/11/18/molnupiravir_2021-11-18_11-02-36414_thumbnail.jpg
)
[1] => Array
(
[ArticleID] => 2140538
[Title] => Merck expects COVID-19 pill to reach rich and poor countries simultaneously
[Summary] => US pharmaceutical giant Merck has vowed to avoid the pitfalls of the global Covid vaccine rollout by ensuring its new anti-coronavirus pill is made available in wealthy and poor countries at almost the same time.
[DatePublished] => 2021-11-11 07:59:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] => https://media.philstar.com/photos/2021/11/11/merck-molnupiravir_2021-11-11_07-59-13_thumbnail.jpg
)
[2] => Array
(
[ArticleID] => 2133582
[Title] => Merck seeks US authorization for COVID-19 treatment pill
[Summary] => Merck has submitted the application for molnupiravir, which it said earlier this month was shown to reduce hospitalizations by 50 percent.
[DatePublished] => 2021-10-12 08:35:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] => 1807254
[AuthorName] => Sarah Titterton
[SectionName] => World
[SectionUrl] => world
[URL] => https://media.philstar.com/photos/2021/10/12/merck-pills_2021-10-12_08-36-00_thumbnail.jpg
)
[3] => Array
(
[ArticleID] => 1365709
[Title] => FDA OKs Merck drug, 1st in new cancer drug class
[Summary] => U.S. regulators have approved the first drug in a new class of cancer medicines that work by stimulating the immune system, a Merck drug developed for treating deadly skin cancer.
[DatePublished] => 2014-09-05 05:14:17
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[4] => Array
(
[ArticleID] => 1347599
[Title] => Studies see new risks for cholesterol drug niacin
[Summary] => New details from two studies reveal more side effects from niacin, a drug that hundreds of thousands of Americans take for cholesterol problems and general heart health. Some prominent doctors say the drug now seems too risky for routine use.
[DatePublished] => 2014-07-18 02:08:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[5] => Array
(
[ArticleID] => 1308007
[Title] => Many Pinoys suffering from neuropathy
[Summary] => Despite its debilitating effects on a person’s life, neuropathy remains an unrecognized and underestimated condition hounding many Filipinos now, according to experts.
[DatePublished] => 2014-04-03 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[6] => Array
(
[ArticleID] => 926523
[Title] => 1 in 10 Filipinos suffer infertility - study
[Summary] => One in 10 Filipinos is suffering one or more conditions that prevent them from conceiving, showed results of a study commissioned by pharmaceutical firm Merck Serono.
[DatePublished] => 2013-04-03 17:06:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] => 1761201
[AuthorName] => Tam Noda
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[7] => Array
(
[ArticleID] => 919989
[Title] => FDA probes new pancreas risks with diabetes drugs
[Summary] => The Food and Drug Administration is looking into new evidence that a group of recently approved diabetes drugs can increase the risk of pancreatitis and other problems.
[DatePublished] => 2013-03-15 01:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => World
[SectionUrl] => world
[URL] =>
)
[8] => Array
(
[ArticleID] => 841594
[Title] => Bristol-Myers ends hepatitis C drug development
[Summary] => Drugmaker Bristol-Myers Squibb Co. has scrapped a potential hepatitis C treatment after a patient participating in a test of the drug died of heart failure.
[DatePublished] => 2012-08-24 08:24:23
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] =>
[SectionUrl] =>
[URL] =>
)
[9] => Array
(
[ArticleID] => 838600
[Title] => Merck Serono marks Neurobion's 50th year
[Summary] => Merck Serono, a division of Merck in Darmstadt, Germany, recently celebrated the 50th anniversary of Neurobion, one of the first vitamin combinations in the world.
[DatePublished] => 2012-08-16 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
merck
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 2259525
[Title] => Drugmaker Merck acquires Prometheus for nearly $11 bn
[Summary] => The company is developing a treatment for autoimmune diseases, including ulcerative colitis and Crohn's disease, dubbed PRA023.
[DatePublished] => 2023-04-17 07:51:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] => https://media.philstar.com/photos/2021/11/18/molnupiravir_2021-11-18_11-02-36414_thumbnail.jpg
)
[1] => Array
(
[ArticleID] => 2140538
[Title] => Merck expects COVID-19 pill to reach rich and poor countries simultaneously
[Summary] => US pharmaceutical giant Merck has vowed to avoid the pitfalls of the global Covid vaccine rollout by ensuring its new anti-coronavirus pill is made available in wealthy and poor countries at almost the same time.
[DatePublished] => 2021-11-11 07:59:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] => https://media.philstar.com/photos/2021/11/11/merck-molnupiravir_2021-11-11_07-59-13_thumbnail.jpg
)
[2] => Array
(
[ArticleID] => 2133582
[Title] => Merck seeks US authorization for COVID-19 treatment pill
[Summary] => Merck has submitted the application for molnupiravir, which it said earlier this month was shown to reduce hospitalizations by 50 percent.
[DatePublished] => 2021-10-12 08:35:00
[ColumnID] => 0
[Focus] => 1
[AuthorID] => 1807254
[AuthorName] => Sarah Titterton
[SectionName] => World
[SectionUrl] => world
[URL] => https://media.philstar.com/photos/2021/10/12/merck-pills_2021-10-12_08-36-00_thumbnail.jpg
)
[3] => Array
(
[ArticleID] => 1365709
[Title] => FDA OKs Merck drug, 1st in new cancer drug class
[Summary] => U.S. regulators have approved the first drug in a new class of cancer medicines that work by stimulating the immune system, a Merck drug developed for treating deadly skin cancer.
[DatePublished] => 2014-09-05 05:14:17
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[4] => Array
(
[ArticleID] => 1347599
[Title] => Studies see new risks for cholesterol drug niacin
[Summary] => New details from two studies reveal more side effects from niacin, a drug that hundreds of thousands of Americans take for cholesterol problems and general heart health. Some prominent doctors say the drug now seems too risky for routine use.
[DatePublished] => 2014-07-18 02:08:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[5] => Array
(
[ArticleID] => 1308007
[Title] => Many Pinoys suffering from neuropathy
[Summary] => Despite its debilitating effects on a person’s life, neuropathy remains an unrecognized and underestimated condition hounding many Filipinos now, according to experts.
[DatePublished] => 2014-04-03 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[6] => Array
(
[ArticleID] => 926523
[Title] => 1 in 10 Filipinos suffer infertility - study
[Summary] => One in 10 Filipinos is suffering one or more conditions that prevent them from conceiving, showed results of a study commissioned by pharmaceutical firm Merck Serono.
[DatePublished] => 2013-04-03 17:06:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] => 1761201
[AuthorName] => Tam Noda
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[7] => Array
(
[ArticleID] => 919989
[Title] => FDA probes new pancreas risks with diabetes drugs
[Summary] => The Food and Drug Administration is looking into new evidence that a group of recently approved diabetes drugs can increase the risk of pancreatitis and other problems.
[DatePublished] => 2013-03-15 01:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => World
[SectionUrl] => world
[URL] =>
)
[8] => Array
(
[ArticleID] => 841594
[Title] => Bristol-Myers ends hepatitis C drug development
[Summary] => Drugmaker Bristol-Myers Squibb Co. has scrapped a potential hepatitis C treatment after a patient participating in a test of the drug died of heart failure.
[DatePublished] => 2012-08-24 08:24:23
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] =>
[SectionUrl] =>
[URL] =>
)
[9] => Array
(
[ArticleID] => 838600
[Title] => Merck Serono marks Neurobion's 50th year
[Summary] => Merck Serono, a division of Merck in Darmstadt, Germany, recently celebrated the 50th anniversary of Neurobion, one of the first vitamin combinations in the world.
[DatePublished] => 2012-08-16 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
November 11, 2021 - 7:59am
September 5, 2014 - 5:14am
August 16, 2012 - 12:00am
